Opaleye Management Inc.
CIK 1595855
13F filing for Q2 2026・No. 2,416
- Holdings
- US$1.1B
- Quarter change
- +US$344.96M
- Entries
- 58
- Net bought (estimate)
- +US$58.73M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 13
- Sold out 9
- Cut 13
- Added 15
- Corporate actions 0
- Unchanged 17
Largest holdings
58 stocks worth US$1.1B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| LIQUIDIA CORPORATIONCOM NEW | Cut | 2,447,500 | US$195.14M | 17.67% |
| ETON PHARMACEUTICALS INCCOM | Unchanged | 2,860,000 | US$103.53M | 9.38% |
| HARROW INCCOM | Cut | 2,400,000 | US$101.93M | 9.23% |
| DISC MEDICINE INCCOM | Added | 855,000 | US$62.53M | 5.66% |
| URGNUROGEN PHARMA LTDCOM | Added | 1,439,996 | US$52.99M | 4.80% |
| APGEAPOGEE THERAPEUTICS INCCOM | Unchanged | 390,000 | US$51.76M | 4.69% |
| MEIRAGTX HLDGS PLCCOM | Added | 3,550,000 | US$47.96M | 4.34% |
| SOL-GEL TECHNOLOGIES LTDSHS NEW | Unchanged | 500,000 | US$37.07M | 3.36% |
| REZOLUTE INCCOM NEW | Unchanged | 6,300,000 | US$32.76M | 2.97% |
| TGTXTG THERAPEUTICS INCCOM | Unchanged | 535,000 | US$29.39M | 2.66% |
Sign in (free) to see its 50 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.